Drug firm GlaxoSmithKline Pharmaceuticals Monday reported a 26 per cent rise in its standalone net profit at Rs 112.97 crore for the quarter ended December 31, 2018, mainly on account of one-time gain of Rs 28 crore.
The company had posted a net profit of Rs 89.69 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.
Standalone revenue from operations of the company stood at Rs 825.35 crore for the quarter under consideration as against Rs 703.91 crore for the same period a year ago.
Commenting on the results, GlaxoSmithKline Pharmaceuticals MD A Vaidheesh said, "The business embarked on its new strategy this year, as we put in place an optimal commercial structure and worked at building capability."
Exceptional items for the quarter ended December 31, 2018, comprise profit from sale of property of Rs 23 crore and non-core brand divestments contributing Rs 5 crore."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
